Navigation Links
NIH awards WSU researcher $1.39M to study chromatin's role in cell division
Date:8/16/2011

DETROIT The National Institute of General Medical Sciences of the National Institutes of Health recently awarded Lori A. Pile, Ph.D., assistant professor of molecular cell biology in Wayne State University's College of Liberal Arts and Sciences, $1.39 million to research how the alteration of chromatin regulates cellular division and growth. The study is intended to support the development of cancer treatments currently undergoing clinical trials.

Chromatin is a DNA-protein structure that resembles a long DNA "string" wrapped around protein "beads." When certain molecules, called chromatin modifiers, react with the protein beads, the entire chromatin structure either decompresses or coils up tightly. "Chromatin modification depends on whether the proteins were acetylated or deacetylated in other words, what kind of modifier reacted with the protein," said Pile.

There are two main types of chromatin modifiers. Histone acetyltransferases (HATs) acetylate the proteins, loosening the chromatin structure. Histone deacetylases (HDACs) deacetylate and tighten DNA's grip on the proteins. A correct balance of action of these chromatin modifiers is necessary for normal cell division. Both activities are required for cells to multiply. But when the balance tips in favor of the deacetylation step, cells can multiply too much, Pile said, and cancer is often the culprit.

That is why deacetylation is being targeted by researchers looking for a way to treat patients with cancer. Yet the exact role of HDACs and deacetylation requires more in-depth exploration.

"While a number of chromatin modifiers are currently being tested as anti-cancer agents in clinical trials, the molecular mechanisms behind their cancer-killing properties are not well understood," said Pile. "Our study is anticipated to clarify these mechanisms and refine the molecular tools designed to target cancer."

These "molecular tools" are histone deacetylase inhibitors, or HDIs. To refine HDIs, Pile will uncover the mechanisms of the target, HDAC chromatin modifiers. She will test a particular HDAC called Swi-independent SIN3 and determine whether SIN3 does, in fact, regulate cell growth and multiplication and, if so, how it affects deacetylation and gene repression.

"Inhibiting HDACs, the agents that fuel unregulated cell division, is anticipated to be an effective approach to preventing cancer progression," said Pile.


'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. International Diabetes Federation awards $2 million to 9 global diabetes research projects
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders
6. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
7. Awards Strengthen Stonhard's Reputation for High-Performing Floors in the World's Most Prominent Pharmaceutical Facilities
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. AADR awards the 2010 Distinguished Mentoring Award to Irwin D. Mandel
10. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Indianapolis, IN (PRWEB) , ... April 25, 2017 ... ... Washington, D.C., CEOs, CFOs and HR decision-makers are preparing for how his administration ... Life Financial will provide insight into what changes are most likely to make ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are ... help with process innovation in drug formulation and manufacturing. CoreRx offers its ... analytical equipment in support of their development and manufacturing goals. , The ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/24/2017)... ... ... Emmanuel College is introducing enhancements to its RN-to-BSN Degree Program ... of 2017, Emmanuel’s program will allow registered nurses (RN)s to earn a Bachelor of ... little as $14,528. These changes will enable nurses to complete their degree in a ...
(Date:4/24/2017)... ... , ... As part of the nationwide Days of Remembrance effort led by ... and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that ... to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
Breaking Medicine Technology: